// App-Quantinova.ai

P1714 : HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS IN EUROPE

Researchers

Presenter

  • Arnaud Jaccard

Principal Investigators

  • Wilfried Roeloffzen

  • Monique C. Minnema

  • Rui Bergantim

  • Roman Hjek

  • Cristina Joao

  • M. Teresa Cibeira

  • Giovanni Palladini

  • Stefan Schnland

  • Giampaolo Merlini

  • Paolo Milani

  • Meletios A. Dimopoulos

  • Sriram Ravichandran

  • Ute Hegenbart

  • Hermine Agis

  • Valeria Magarotto

  • Alexandros Leonidakis

  • Pieter Sonneveld

  • Ashutosh Wechalekar

  • Efstathios Kastritis

Medical Centers

  • National Amyloidosis

  • Medical Department V, Amyloidosis Center Heidelberg,University of Heidelberg,Heidelberg,Allemagne

  • Nephrology Unit,CHU Poitiers,Poitiers,Frankreich

  • Hematology Department,Champalimaud Center for the Unknown,Lisbon,Portogallo

  • Janssen-Cilag S.A.,Madrid,Espanha

  • Department of Internal M

  • Health Data Specialists,Dublin,Ireland

  • Department of Haematology,University Medical Centre Utrecht, Utrecht University,Utrecht,Paesi Bassi

  • Amyloidosis Research and Treatment Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy

  • Amyloidosis

  • Hemostaseology, Medical University Vienna,Vienna,Austria

  • Department of Internal Medicine Division of Rheumatology

  • Department of Clinical Therapeutics, School

  • Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

  • National Amyloidosi

  • Amyloidosis Research and Treatment Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy

  • Nephrology Unit,CHU Poitiers,

  • Hemostaseology, Medical University Vienna,Vienna,Austria

  • National Amyloidosis Centre, University College London, London, United Kingdom

  • Janssen-Cilag S.A.,Rome,Italy

  • Health Data Specialists,Dublin,Ireland

  • National Amyloidosis Centre,University College London (Royal Free Campus),London,Royaume-uni

  • Janssen-Cilag S.A.,London,Соединённое Королевство

  • Janssen-Cilag S.A.,Rome,Italy

  • Amyloidosis Centre of Expertise, Department of Internal Medicine, Faculty of Medical Sciences,Unive

  • Department of Haematology,University Medical Centre Utrecht, Utrecht University,Utrecht,Paesi Bassi

  • Janssen-Cilag S.A.,Rome,Италия

  • Amyloidosis and Myeloma Unit, Department of Hematology,Hospital Clinic, IDIBAPS,Barcelona,Espagne

  • Janssen-Cilag S.A.,Rome,Italy

  • Janssen-Cilag S.A.,Madrid,Испания

  • Janssen-Cilag S.A.,Madrid,Espanha

  • Janssen-Cilag S.A.,London,United Kingdom

  • Janssen-Cilag S.A.,Madrid,Espanha

  • Amyloidosis and Myeloma Unit. Department of Hematology,Hospital Clinic. IDIBAPS,Barcelona,Spain;Faculty of Medicine,University of Barcelona,Barcelona,Spain

  • Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands

  • Health Data Specialists,Dublin,Ireland

  • Department of Hematooncology,University Hospital,Ostrava,República Checa

  • Hematology Department,Champalimaud Center for the Unknown,Lisbon,Portogallo

  • Department of Hematooncology,University Hospital,Ostrava,República Checa

  • Medical D

  • Amyloidosis and Myeloma Unit, Department of Hematology,Hospital Clinic, IDIBAPS,Barcelona,Espagne

  • Department of Haematology,University Medical Centre Utrecht, Utrecht University,Utrecht,Paesi Bassi

  • Nephrology Unit,CHU Poitiers,Poitiers,Frankreich

  • Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands

  • Nephrology Unit,CHU Poitiers,Poitiers,Frankreich

  • Hematology,Erasmus MC Cancer Institute,Rotterdam,Paesi Bassi

  • Janssen-Cilag S.A.,Rome,Italy

  • Hematology,Erasmus MC Cancer Institute,Rotterdam,Paesi Bassi

  • Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, ATHENS, Greece

  • National Amyloidosis Center and Hematology Unit,CHU Limoges,Limoges,Francia

  • Department of Hematology,Hospital São João,Porto,Portogallo

  • Department of Hematooncology,University Hospital,Ostrava,República Checa

  • Janssen-Cilag S.A.,Madrid,Espanha

  • Nephrology Unit,CHU Poitiers,Poitiers,Frankreich

  • National Amyloidosis Centre,University College London,London,Vereinigtes Königreich

  • Erasmus MC Cancer Center, Rotterdam, Netherlands

  • Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany

  • Department of Hematology,Hospital São João,Porto,Portogallo

  • Department of Hematooncology,University Hospital,Ostrava,República Checa

  • National Amyloidosis Centre, University College London, London, United Kingdom

  • Hematology,Erasmus MC Cancer Institute,Rotterdam,Paesi Bassi

  • Erasmus MC Institute,Rotterdam,Netherlands

  • Janssen-Cilag S.A.,London,Regno Unito

  • Janssen-Cilag S.A.,Rome,Italy

  • National Amyloidosis Center and Hematology Unit,CHU Limoges,Limoges,Francia

  • Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

  • Hematology,Erasmus MC Cancer Institute,Rotterdam,Paesi Bassi

  • Janssen-Cilag S.A.,Madrid,Espanha

  • Erasmus MC Cancer Institute,Rotterdam,Нидерланды

  • Janssen-Cilag S.A.,Rome,Italy

  • Janssen-Cilag S.A.,London,Vereinigtes Königreich

  • Janssen-Cilag S.A.,London,Regno Unito

  • Nephrology Unit,CHU Poitiers,Poitiers,Франция

  • Janssen-Cilag S.A.,London,Verenigd Koninkrijk

  • National Amyloidosis Centre, University College London, London, United Kingdom

  • Nephrology Unit,CHU Poitiers,Poitiers,Frankreich

  • Erasmus MC,

  • Hemostaseology, Medical University Vienna,Vienna,Austria

  • Amyloidosis Centre of Expertise Department of Internal Medicine, Faculty of Medical Sciences,, University Medical Center Groningen, Groningen, Netherlands

  • Janssen-Cilag S.A.,London,Storbritannien

  • Department of Hematooncology,University Hospital,Ostrava,República Checa

  • Health Data Specialists,Dublin,Ирландия

  • Amyloidosis and Myeloma Unit, Department of Hematology,Hospital Clinic, IDIBAPS,Barcelona,Espagne

  • Janssen-Cilag S.A.,Madrid,Espanha

  • Departament of Urology, Hospital Sao Joao, Porto, Portugal

  • Janssen-Cilag S.A.,Madrid,Espanha

  • Janssen-Cilag S.A.,London,Royaume-uni

  • Health Data Specialists,Dublin,Ireland

  • Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany

  • Departme

  • Health Data Specialists,Dublin,Ireland

  • Medical Department V, Amyloidosis Center Heidelberg,University of Heidelberg,Heidelberg,Allemagne

  • National Amyloidosis Center and Hematology Unit,CHU Limoges,Limoges,Francia

  • Hematology Department,

  • Amyloidosis Centre of Expertise Department of Internal Medicine, Faculty of Medical Sciences,, University Medical Center Groningen, Groningen, Netherlands

Locations

  • France

  • Netherlands

  • Portugal

  • Czech Republic

  • Venezuela

  • Spain

  • Italy

  • South Africa

  • Germany

  • United States

  • United Kingdom

  • Austria

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Peripheral Nervous System

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • AL Amyloidosis

  • Peripheral neuropathy

  • Congestive heart failure

  • Amyloid disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved